The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
A Separate Disease Within the Syndrome of Schizophrenia
Abstract
If schizophrenia is a clinical syndrome rather than a single disease, the identification of specific diseases within the syndrome would facilitate the advance of knowledge and the development of more specific treatments. We propose that deficit psychopathology (ie, enduring, idiopathic negative symptoms) defines a group of patients with a disease different from schizophrenia without deficit features, as the deficit and nondeficit groups differ in their signs and symptoms, course, biological correlates, treatment response, and etiologic factors. These differences cannot be attributed to more severe positive psychotic symptoms or a greater duration of illness in the deficit group. The alternative interpretation that patients with deficit schizophrenia are at the severe end of a single disease continuum is not supported by risk factor and biological features data, but there is a need for independent replication of these findings. We suggest a series of studies designed to falsify one of these hypotheses, ie, multiple diseases vs a single disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Platt, J. R. (1964) · Science · doi:10.1126/science.146.3642.347 · Cited by 2,907
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,901
Alexander, G. E., Crutcher, M. D., & DeLong, M. R. (1990) · PubMed · Cited by 2,679
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Establishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia
ROBINS, E., & GUZE, S. B. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.126.7.983 · Cited by 2,243
Negative v Positive Schizophrenia: Definition and Validation
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,012
Deficit and nondeficit forms of schizophrenia: the concept
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.578 · Cited by 1,332
Risperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
Patterns of Cerebral Blood Flow in Schizophrenia
Liddle, P. F., Friston, K. J., Frith, C. D., Hirsch, S. R., Jones, T., & Frackowiak, R. S. J. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.179 · Cited by 900
Cited by
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
Insel, T. R. (2010) · Nature · doi:10.1038/nature09552 · Cited by 1,783
The NIMH-MATRICS Consensus Statement on Negative Symptoms
Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311
Self-citationPsychiatric Comorbidities and Schizophrenia
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn135 · Cited by 1,121
Garland, E. L., Fredrickson, B., Kring, A. M., Johnson, D. P., Meyer, P. S., & Penn, D. L. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.03.002 · Cited by 1,035
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
The brief negative symptom scale: Psychometric properties
Kirkpatrick, B., Strauss, G. P., Nguyen, L., Fischer, B. A., Daniel, D. G., Cienfuegos, A., & Marder, S. R. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq059 · Cited by 895
Self-citationCorrell, C. U., & Schooler, N. R. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s225643 · Cited by 911
Ross, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M., & Coyle, J. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.015 · Cited by 686
The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment
Blanchard, J. J., & Cohen, A. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj013 · Cited by 649
Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
Foussias, G., & Remington, G. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn094 · Cited by 594
“’’(12) The prevalence of the deficit syndrome has since been estimated at approximately 15% in first-episode patients and 25%–30% in chronic schizophrenia.(13)”
BackgroundPantelis, C. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi034 · Cited by 573
Negative symptoms of schizophrenia: new developments and unanswered research questions
Galderisi, S., Mucci, A., Buchanan, R. W., & Arango, C. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30050-6 · Cited by 555
Self-citationEmotional Experience in Patients With Schizophrenia Revisited: Meta-analysis of Laboratory Studies
Cohen, A. S., & Minor, K. S. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn061 · Cited by 541
The current conceptualization of negative symptoms in schizophrenia
Marder, S. R., & Galderisi, S. (2017) · World Psychiatry · doi:10.1002/wps.20385 · Cited by 537
Persistent Negative Symptoms in Schizophrenia: An Overview
Buchanan, R. W. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl057 · Cited by 443
Self-citationBuchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi020 · Cited by 438
Self-citationNegative Symptoms of Schizophrenia Are Associated with Abnormal Effort-Cost Computations
Gold, J. M., Strauss, G. P., Waltz, J. A., Robinson, B. M., Brown, J. K., & Frank, M. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.022 · Cited by 421
Bora, E., Fornito, A., Radua, J., Walterfang, M., Seal, M., Wood, S. J., Yücel, M., Velakoulis, D., & Pantelis, C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.12.020 · Cited by 436
Strauss, G. P., Horan, W. P., Kirkpatrick, B., Fischer, B. A., Keller, W. R., Miski, P., Buchanan, R. W., Green, M. F., & Carpenter, W. T. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.01.015 · Cited by 422
Self-citationCognitive deficits as treatment targets in schizophrenia
Gold, J. M. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.008 · Cited by 354
Millan, M. J., Fone, K., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 347
The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum
Guloksuz, S., & van Os, J. (2018) · Psychological Medicine · doi:10.1017/s0033291717001775 · Cited by 325
Linscott, R. J., & van Os, J. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153506 · Cited by 324
Long-Term Follow-Up of the TIPS Early Detection in Psychosis Study: Effects on 10-Year Outcome
Hegelstad, W. T. V., Larsen, T. K., Auestad, B., Evensen, J., Haahr, U., Joa, I., Johannesen, J. O., Langeveld, J., Melle, I., Opjordsmoen, S., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030459 · Cited by 309
The diagnostic concept of schizophrenia: its history, evolution, and future prospects
Jablensky, A. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/ajablensky · Cited by 306
First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome
Malla, A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi031 · Cited by 288
Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia
Kehrer, C. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.006.2008 · Cited by 287
Chaudhry, I. B., Hallak, J., Husain, N., Minhas, F., Stirling, J., Richardson, P., Dursun, S., Dunn, G., & Deakin, B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444941 · Cited by 279
Bora, E., Yucel, M., & Pantelis, C. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp094 · Cited by 276
Messinger, J. W., Trémeau, F., Antonius, D., Mendelsohn, E., Prudent, V., Stanford, A. D., & Malaspina, D. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.09.002 · Cited by 271
Bobes, J., Arango, C., Garcia-Garcia, M., Rejas, J., & CLAMORS Study Collaborative Group (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04250yel · Cited by 271
Subtyping schizophrenia: implications for genetic research
Jablensky, A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001857 · Cited by 268
Freudenreich, O., & Goff, D. C. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.01331.x · Cited by 259
Do Patients with Schizophrenia Ever Show Periods of Recovery? A 15-Year Multi-Follow-up Study
Harrow, M. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi026 · Cited by 252
Lutgens, D., Gariepy, G., & Malla, A. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.197103 · Cited by 181
Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications
Coyle, J. T., Basu, A., Benneyworth, M., Balu, D., & Konopaske, G. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-25758-2_10 · Cited by 180
Buchanan, R. W., Keefe, R. S. E., Umbricht, D., Green, M. F., Laughren, T., & Marder, S. R. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq038 · Cited by 154
Self-citationSocial Neuroscience: Progress and Implications for Mental Health
Cacioppo, J. T., Amaral, D. G., Blanchard, J. J., Cameron, J. L., Carter, C. S., Crews, D., Fiske, S., Heatherton, T., Johnson, M. K., Kozak, M. J., et al. (2007) · Perspectives on Psychological Science · doi:10.1111/j.1745-6916.2007.00032.x · Cited by 135
Is late‐onset schizophrenia a subtype of schizophrenia?
Vahia, I. V., Palmer, B. W., Depp, C., Fellows, I., Golshan, S., Kraemer, H. C., & Jeste, D. V. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01552.x · Cited by 119
Histone modifications, DNA methylation, and Schizophrenia
Gavin, D. P., & Sharma, R. P. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.010 · Cited by 121
Carpenter, W. T., Bustillo, J. R., Thaker, G. K., van Os, J., Krueger, R. F., & Green, M. J. (2009) · Psychological Medicine · doi:10.1017/s0033291709990286 · Cited by 99
Self-citationPredictors of Relapse and Functioning in First-Episode Psychosis: A Two-Year Follow-Up Study
Bergé, D., Mané, A., Salgado, P., Cortizo, R., Garnier, C., Gomez, L., Diez-Aja, C., Bulbena, A., & Pérez, V. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201400316 · Cited by 96
Ho, N. F., Chong, P. L. H., Lee, D. R., Chew, Q. H., Chen, G., & Sim, K. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000207 · Cited by 89
Bader, V., Tomppo, L., Trossbach, S. V., Bradshaw, N. J., Prikulis, I., Leliveld, S. R., Lin, C.-Y., Ishizuka, K., Sawa, A., Ramos, A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds273 · Cited by 70
Wolf, D. H. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0069-0 · Cited by 66
Dickinson, D., Pratt, D. N., Giangrande, E. J., Grunnagle, M., Orel, J., Weinberger, D. R., Callicott, J. H., & Berman, K. F. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx039 · Cited by 62
Dyck, M. S., Mathiak, K. A., Bergert, S., Sarkheil, P., Koush, Y., Alawi, E. M., Zvyagintsev, M., Gaebler, A. J., Shergill, S. S., & Mathiak, K. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00037 · Cited by 56
Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going?
Keller, W. R., Fischer, B. A., & Carpenter Jr., W. T. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00229.x · Cited by 46
Involvement of the mirror neuron system in blunted affect in schizophrenia
Lee, J. S., Chun, J. W., Yoon, S. Y., Park, H.-J., & Kim, J.-J. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.043 · Cited by 45
Understanding anhedonia in schizophrenia through lexical analysis of natural speech
Cohen, A. S., St-Hilaire, A., Aakre, J. M., & Docherty, N. M. (2009) · Cognition and Emotion · doi:10.1080/02699930802044651 · Cited by 41
Sch-net: a deep learning architecture for automatic detection of schizophrenia
Fu, J., Yang, S., He, F., He, L., Li, Y., Zhang, J., & Xiong, X. (2021) · BioMedical Engineering OnLine · doi:10.1186/s12938-021-00915-2 · Cited by 31
Ahmed, A. O., Murphy, C. F., Latoussakis, V., McGovern, K. E., English, J., Bloch, A., Anthony, D. T., & Savitz, A. J. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.001 · Cited by 22
Metadata
- Authors
- Kirkpatrick, B., Buchanan, R. W., Ross, D. E., & Carpenter, W. T.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2001-02-01
- Volume
- 58
- Issue
- 2
- Pages
- 165
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2010407531
- Cited by
- 651
- References
- 75
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.